fda glp-1 compounding warning letters september 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers CDER Warning Letters Jump 50%

Scientific attention surrounding DSIP has increased significantly as modern peptide research continues exploring recovery-focused and nervous-system-related peptides

Ongoing preclinical studies in human pituitary cell lines and the phase 3 study of relacorilant in patients with Cushing syndrome (clinicaltrials.gov NCT03697109), which includes tumor imaging, may provide additional insight

Building research capacity in this area is essential to enhance the early detection of disease states and provide crucial information about the disease risk of offspring conceived through assisted reproduction

No peer-reviewed clinical trials have evaluated the combined use of lipotropic injections and tirzepatide for weight management or metabolic outcomes

Surveys suggest one in three employers currently covering the drugs are considering scaling back

Healthy Lifestyle How anti-depressants can increase your risk for heat exhaustion If you use anti-depressants, you may be at greater risk for experiencing heat exhaustion